Patent · US Active

Method for chemical synthesis of antrocin and use thereof for suppressing non-small cell lung cancer

US9045450B2 · kind B2 · utility

1Cited by
1References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 10, 2011
Grant dateJun 2, 2015
Priority date
Expiry dateAug 10, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a method for preparing antrocin of pharmaceutically acceptable salts thereof via a series of gold-catalyzed cyclization to construct the (6-6-5) tricyclic core frame. The present invention also provides a use of a composition in preparing drugs for suppressing growth of non-small cell lung cancer cells, wherein the composition comprises an effective amount of antrocin or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.